Rice Hall James & Associates’s Vericel VCEL Stock Holding History
Bought
Maintained
Sold
Other funds holding VCEL
Rice Hall James & Associates's VCEL Position: Q3 2026 in Review
Rice Hall James & Associates increased its Vericel (VCEL) stake by 101% in Q3 2026, buying an estimated $6.1M and bringing the position to 279,677 shares worth $11.2M. The position accounts for 0.6% of the portfolio, ranked #53.
Rice Hall James & Associates first reported a position in VCEL in Q3 2025 and has held it in 5 quarters since. 320 funds tracked by Wall St. Rank hold VCEL as of Q3 2026.
- Rice Hall James & Associates held 279,677 shares of Vericel worth $11.2M as of Q3 2026.
- Rice Hall James & Associates bought 140,837 Vericel shares in Q3 2026, an estimated $6.1M.
- Vericel made up 0.6% of Rice Hall James & Associates's portfolio in Q3 2026, its #53 holding.
- Rice Hall James & Associates first reported a position in Vericel in Q3 2025 and has held it in 5 quarters since.
- 320 funds tracked by Wall St. Rank held Vericel as of Q3 2026.
Based on Rice Hall James & Associates's 13F filing for Q3 2026, filed 16 Nov 2026.